Truth Behind UK's E-cigarette Craze: What's in Them?

Industry Insight by 2FIRSTS.ai
Dec.08.2023
Truth Behind UK's E-cigarette Craze: What's in Them?
BBC to release documentary "What's Inside e-cigarettes?" in 2024, investigating the truth behind the UK e-cigarette trend.

According to a report by The Lancashire Telegraph on December 8th, the BBC is set to launch a documentary titled "What's in an e-cigarette?" in 2024. The documentary aims to delve into the truth behind the e-cigarette craze in the United Kingdom.

 

In recent years, there has been a tremendous surge in the number of young people using e-cigarettes in the United Kingdom. Recent data reveals that the annual sales revenue in the country has surpassed a staggering £1.3 billion.

 

Do the public truly know what is inside these e-cigarettes? What are they made of, how are they made, and where are they made? What chemicals are present in the liquid? How much nicotine do they actually contain? Which ones are legally sold, and which ones are not?

 

BBC presenter and avid e-cigarette user, Jordan North, will meet with scientists conducting tests on the latest e-cigarettes and researchers exploring their potential long-term effects in response to the aforementioned concerns and more. Additionally, he will investigate the issue of illegal e-cigarettes in the United Kingdom.

 

Jordan expressed, "I have always wanted to create a documentary on a subject that I am extremely interested in. As an enthusiast of e-cigarettes, I am very curious to explore what goes inside my e-cigarette!

 

Executive producer Andrew Eastel stated:

 

Therefore, it is now more important than ever for us to better understand the actual components within e-cigarettes, their manufacturing processes and origins, the types or brands of e-cigarettes that may pose risks, and the potential long-term effects on the health of e-cigarette users.

 

The documentary "What's Inside E-cigarettes?" is set to premiere on BBC 3 channel and BBC iPlayer in early 2024.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Luxembourg Passes Bill 8333: Heated Tobacco and Nicotine Pouches Regulated
Luxembourg Passes Bill 8333: Heated Tobacco and Nicotine Pouches Regulated
Luxembourg’s Chamber of Deputies adopted Bill No. 8333, transposing EU Directive 2022/2100 and extending tobacco controls to heated tobacco, e-cigarettes and nicotine pouches. The law bans flavourings, restricts sales to minors, and caps nicotine content at 0.048 mg per pouch. CBD and caffeine additives are prohibited.
Nov.03 by 2FIRSTS.ai
Jinjia Venture Faces New Judicial Auction, Control Unchanged
Jinjia Venture Faces New Judicial Auction, Control Unchanged
Jinjia Group said its controlling shareholder, Jinjia Venture, will have part of its holdings auctioned by the Shenzhen Nanshan Court, involving 43.4 million shares. Earlier, the Shenzhen Intermediate Court announced another auction of 37.27 million shares. Together they represent 5.56% of total equity. Jinjia said the auctions will not affect company control.
Oct.23 by 2FIRSTS.ai
Geek Bar Launches New Pulse Models in the U.S.: Thermochromic Design, Core Specs Intact
Geek Bar Launches New Pulse Models in the U.S.: Thermochromic Design, Core Specs Intact
U.S. vape retailer VapeSourcing has listed GEEKBAR Pulse 15K/25K Thermal Edition products, currently marked “Coming Soon.” Both models retain the core Pulse-series configuration but adopt a thermochromic, color-changing shell; the Pulse 15K is flagged as GEEKBAR’s first device to use this finish.
Nov.04 by 2FIRSTS.ai
Chonburi Police Raid Major E-Cigarette and Vape Liquid Warehouse Worth Over US$920,000
Chonburi Police Raid Major E-Cigarette and Vape Liquid Warehouse Worth Over US$920,000
Thailand Chonburi provincial police, in coordination with multiple agencies, raided a large-scale warehouse in downtown Chonburi used for producing and distributing e-cigarettes and vape liquids. Two Chinese nationals were arrested, and more than 40 categories of contraband—including vapes, e-liquids, and production equipment—were seized, with an estimated total value exceeding US$920,000 (about 30 million Thai baht).
Nov.17 by 2FIRSTS.ai
British American Tobacco’s VELO Launches Limited McLaren F1 Edition: US Price Only 60% of EU/UK
British American Tobacco’s VELO Launches Limited McLaren F1 Edition: US Price Only 60% of EU/UK
BAT’s VELO has released a McLaren F1 co-branded, track-themed limited-edition pack in McLaren’s orange-black livery. Pricing is about $4.60 per can in the U.S. versus ~$7.40 in the EU/UK. The collaboration extends BAT’s partnership with McLaren dating back to 2019.
Oct.11 by 2FIRSTS.ai